Literature DB >> 21912016

The Oxford classification of IgA nephropathy: a role model for classifying other renal diseases.

Muhammed Mubarak1.   

Abstract

The Oxford classification of IgA nephropathy (IgAN) has been developed as an international consensus- and evidence-based pathological classification system to accurately predict the risk of disease progression in individual patients. The classification system needs to be validated in independent studies throughout the world using the entire spectrum of IgAN cases. With further refinements and fine tuning, this system may help in determining individualized treatment and risk prediction for patients with IgAN.

Entities:  

Mesh:

Year:  2011        PMID: 21912016

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  5 in total

1.  Oxford classification of IgA nephropathy: Broadening the scope of the classification.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2012-04-05

2.  Oxford-MEST classification in IgA nephropathy patients: A report from Iran.

Authors:  Hamid Nasri; Mojgan Mortazavi; Ali Ghorbani; Heshmatollah Shahbazian; Soleiman Kheiri; Azar Baradaran; Afsoon Emami-Naieni; Maryam Saffari; Saeed Mardani; Ali Momeni; Yahya Madihi; Milad Baradaran-Ghahfarokhi; Mahmoud Rafieian-Kopaie; Parin Hedayati; Shahzad Baradaran; Mohammadreza Ardalan; Shahram Sajjadieh; Naziheh Assarzadegan; Seyed Mohammad Ahmadi Soleimani; Mohamad Reza Tamadon
Journal:  J Nephropathol       Date:  2012-04-05

3.  Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2013-07-01

Review 4.  What nephrolopathologists need to know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions?

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Nephropathol       Date:  2014-01-01

5.  ISN/RPS 2003 classification of lupus nephritis: time to take a look on the achievements and limitations of the schema.

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Nephropathol       Date:  2014-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.